Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Asphyxia Neonatorum

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Asphyxia Neonatorum in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Asphyxia Neonatorum: Respiratory failure in the newborn. (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fritz, KI1
Zanelli, S1
Mishra, OP1
Delivoria-Papadopoulos, M1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Asphyxia Neonatorum

ArticleYear
Effect of graded hypoxia on the high-affinity CPP binding site of the NMDA receptor in the cerebral cortex of newborn piglets.
    Brain research, 2001, Feb-09, Volume: 891, Issue:1-2

    Topics: Animals; Animals, Newborn; Asphyxia Neonatorum; Binding Sites; Cell Membrane; Cerebral Cortex; Disea

2001